TY  - GEN
AU  - Tiberghien,P
AU  - Racadot,E
AU  - Fest,T
AU  - Lioure,B
AU  - Pariset,J
AU  - Delain,M
AU  - Voillat,L
AU  - Flesch,M
AU  - Amsallem,D
AU  - Plouvier,E
TI  - IL-2 treatment after autologous bone marrow transplantation in poor prognosis Hodgkin's disease: defective IL-2-induced LAK activity?
SN  - 0268-3369
PY  - 1991///0927
KW  - Adolescent
KW  - Adult
KW  - Bone Marrow Transplantation
KW  - Child
KW  - Combined Modality Therapy
KW  - Drug Evaluation
KW  - Hodgkin Disease
KW  - immunology
KW  - Humans
KW  - Immunologic Factors
KW  - pharmacology
KW  - Interleukin-2
KW  - Killer Cells, Lymphokine-Activated
KW  - drug effects
KW  - Killer Cells, Natural
KW  - Transplantation, Autologous
N1  - Publication Type: Clinical Trial; Journal Article
ER  -